Meet 3D-TRUBI
3D Transcranial Ultrasound Brain Imaging
3D-TRUBI is an easy-to-use, ruggedized, portable, lightweight, shock and impact resistant device suitable for use in austere combat and civilian environments by medical personnel with all levels of training.
3D Imaging of intracranial hemorrhages and determining their types
Point-of-Injury (POI) / Point-of-Initial-Care (POIC) diagnostic imaging
Ruggedized, Portable, Lightweight, Shock and Impact Resistant
Short learning curve, Easy-to-use and User-friendly
Our Technology
As a spin-off from Tessonics Corporation, TMS currently focuses on further development and commercialization of the 3D Transcranial Ultrasound Brain Imaging (3D-TRUBI) technology that has been originally developed by Tessonics Corporation during the past decade. TMS aims to implement the 3D-TRUBI technology in an advanced ultrasound diagnostic imaging instrument that will provide a forward-deployable solution for rapid and accurate diagnosis of life-threatening traumatic brain injuries (TBI).
3D-TRUBI in Action
Below images and animation shows the effectiveness of 3D-TRUBI for primary and differential diagnosis of Intracranial Hematomas (ICT)
Type 1:
Epidural Hematoma
CT (Gold Standard)
3D TRUBI (Uncorrected)
3D TRUBI (Corrected)
Type 2:
Subdural Hematoma
CT (Gold Standard)
3D TRUBI (Uncorrected)
3D TRUBI (Corrected)
Type 3:
Intracerebral Hematoma
CT (Gold Standard)
3D TRUBI (Uncorrected)
3D TRUBI (Corrected)
Our Story
Tessonics Medical Systems Inc. (TMS) was founded in Birmingham, MI, USA, in 2019. TMS focuses on developing innovative diagnostic instrumentation solutions to enhance medical readiness, reduce fatalities, optimally treat life-threatening injuries, and promote positive long-term outcomes.
The primary focus of TMS is to further develop and commercialize the 3D Transcranial Ultrasound Brain Imaging (3D-TRUBI) technology pioneered by Tessonics Corporation over the past decade. This endeavor has also been supported by an award from the Office of the Assistant Secretary of Defense for Health Affairs (OASDHA).*
TMS aims to implement the 3D-TRUBI technology in an advanced ultrasound diagnostic imaging instrument that will provide a forward-deployable solution for rapid and accurate diagnosis of life-threatening brain hemorrhages associated with traumatic brain injuries (TBI). 3D-TRUBI is preparing for Phase I clinical studies in Q3 2024, with funding approved at the Brooke Army Medical Center in San Antonio, TX.**
*Combat Readiness – Medical Research Program – Rapid Development and Translational Research Award No. W81XWH-20-1-0852.
**Military Traumatic Brain Injury Initiative (MTBI2) – Uniformed Services University of the Health Sciences
PRESIDENT & CEO
Roman Gr. Maev
Dr. Roman Gr. Maev is the founding President and CEO of Tessonics Medical Systems Inc., a 2019 spin-off from Tessonics Group, a global leader specializing in design, development, and production of ultrasonic equipment for industrial and medical applications.
CHIEF MEDICAL OFFICER
Juri Gelovani
Dr. Juri Gelovani is the co-founder and Chief Medical Officer (CMO) at Tessonics Medical Systems Inc., Birmingham, MI, USA. He has clinical training in Neurosurgery and Neuroimaging, and he is the pioneer of molecular-genetic in-vivo imaging.
CHIEF TECHNOLOGY OFFICER
Kiyan Shapoori
Dr. Kiyan Shapoori is co-founder and Chief Technology Officer (CTO) at Tessonics Medical Systems Inc., Birmingham, MI, USA. He received his B.Sc. in Physics, his M.Sc. in Biomedical Physics, and his Ph.D. in Biomedical Engineering.
R&D DIRECTOR
Eugene Malyarenko
Dr. Eugene Malyarenko is co-founder and R&D Director at Tessonics Medical Systems Inc., Birmingham, MI. He has broad academic background and extensive practical experience in Physical Acoustics and Computer Science. He received his PhD degree in Applied Science/Nondestructive Evaluation in 2000.
DIRECTOR OF STRATEGY
Anna Maeva
Anna Maeva is co-founder and Director of Strategy at Tessonics Medical Systems Inc. She received her B.Sc. in Chemistry with minor in Physics, her M.Sc in Medical Biophysics and is currently finishing her Ph.D. in Biomedical Physics and Tissue Engineering at UCL, London, UK.
Get in Touch
We would like to hear from you!
